IL-6 release from skeletal muscles is linked to glycogen depletion in muscle, which is in contrast to what is observed in COVID-19 and related diseases, where IL-6 elevation is a result of injury and inflammation in infected cells/tissues [101,102]. This evidence concerns the gene IL6 and COVID-19.